HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Secretory leukocyte protease inhibitor promotes the tumorigenic and metastatic potential of cancer cells.

Abstract
Because of their ability to inhibit proteases, protease inhibitors have generally been considered to counteract tumor progression and metastasis. However, expression of serine protease inhibitors (SPIs) in tumors is often associated with poor prognosis of cancer patients. Moreover, there is growing evidence that SPIs may even promote malignancy of cancer cells, opening new avenues for their use as biomarkers in malignancy. To isolate cancer promoting genes, we applied the suppression subtractive hybridization method to low-malignant Lewis Lung Carcinoma 3LL-S versus high-malignant 3LL-S-sc cells. This resulted in the identification of the SPI secretory leukocyte protease inhibitor (SLPI), as one of the genes whose expression was higher in 3LL-S-sc than in 3LL-S cells. By stable transfection of 3LL-S cells with mouse or human SLPI, we demonstrated that elevated levels of SLPI expression increased both the tumorigenicity and lung-colonizing potential of 3LL-S cells. Moreover, we showed that this function of SLPI depended on its protease inhibitory capacity. Our results also reveal that although SLPI enhanced the proliferation of 3LL-S cells in vitro, its promalignant activity in vivo was not solely due to its effect on cell proliferation. In this study, we report a causal role for SLPI in the malignant behavior of cancer cells, underscoring the potential malignancy-promoting activities of SPIs.
AuthorsNick Devoogdt, Gholamreza Hassanzadeh Ghassabeh, Jing Zhang, Lea Brys, Patrick De Baetselier, Hilde Revets
JournalProceedings of the National Academy of Sciences of the United States of America (Proc Natl Acad Sci U S A) Vol. 100 Issue 10 Pg. 5778-82 (May 13 2003) ISSN: 0027-8424 [Print] United States
PMID12732717 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA Primers
  • Proteinase Inhibitory Proteins, Secretory
  • Proteins
  • SLPI protein, human
  • Secretory Leukocyte Peptidase Inhibitor
  • Slpi protein, mouse
Topics
  • Animals
  • Base Sequence
  • Cell Division
  • Cell Line
  • DNA Primers
  • Humans
  • Kinetics
  • Lung Neoplasms (pathology)
  • Mice
  • Mice, Inbred C57BL
  • Mice, SCID
  • Neoplasm Metastasis (pathology)
  • Precancerous Conditions (pathology)
  • Proteinase Inhibitory Proteins, Secretory
  • Proteins (genetics, metabolism)
  • Secretory Leukocyte Peptidase Inhibitor
  • Transfection
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: